BANK OF AMERICA CORP /DE/ - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 39 filers reported holding ENTRADA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$368,835
+11.7%
23,344
+7.0%
0.00%
Q2 2023$330,324
-32.5%
21,818
-35.4%
0.00%
Q1 2023$489,680
+583.9%
33,771
+537.7%
0.00%
Q4 2022$71,602
+13.7%
5,296
+33.5%
0.00%
Q3 2022$63,000
-60.1%
3,966
-69.5%
0.00%
Q2 2022$158,000
-19.4%
12,991
-37.8%
0.00%
Q1 2022$196,000
-49.9%
20,871
-8.6%
0.00%
Q4 2021$391,00022,8420.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
72 Investment Holdings, LLC 509,023$8,042,56353.88%
MPM ASSET MANAGEMENT LLC 4,425,784$69,927,38737.45%
5AM Venture Management, LLC 4,408,379$69,652,38820.04%
StepStone Group LP 761,277$12,028,1772.68%
TCG Crossover Management, LLC 584,955$9,242,2891.36%
Redmile Group, LLC 1,284,000$20,287,2000.96%
Nan Fung Group Holdings Ltd 49,082$775,4960.63%
Baker Brothers Advisors 4,865,819$76,879,9400.44%
Corton Capital Inc. 10,485$165,6630.08%
CORNERCAP INVESTMENT COUNSEL INC 13,977$220,8370.04%
View complete list of ENTRADA THERAPEUTICS INC shareholders